Co-Authors
This is a "connection" page, showing publications co-authored by JUAN LOPEZ-MATTEI and KAVEH KARIMZAD.
Connection Strength
0.576
-
QT Prolongation in Cancer Patients. Front Cardiovasc Med. 2021; 8:613625.
Score: 0.192
-
Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med. 2022; 9:1019284.
Score: 0.054
-
Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease. Medicina (Kaunas). 2022 Jul 01; 58(7).
Score: 0.053
-
Cardiac Interventional Procedures in Cardio-Oncology Patients. Cardiol Clin. 2019 Nov; 37(4):469-486.
Score: 0.044
-
Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol. 2019 08; 19(4):382-387.
Score: 0.043
-
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol. 2019 04 15; 123(8):1351-1357.
Score: 0.042
-
Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Front Cardiovasc Med. 2018; 5:48.
Score: 0.040
-
Progressive and Reversible Conduction Disease With Checkpoint Inhibitors. Can J Cardiol. 2017 10; 33(10):1335.e13-1335.e15.
Score: 0.037
-
Ischemic Heart Disease: Special Considerations in Cardio-Oncology. Curr Treat Options Cardiovasc Med. 2017 May; 19(5):37.
Score: 0.037
-
Takotsubo Stress Cardiomyopathy: "Good News" in Cancer Patients? J Am Coll Cardiol. 2016 09 06; 68(10):1143-4.
Score: 0.035